Trial Profile
Phase I trial evaluating the tolerability of YKP 10811 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Dec 2012
Price :
$35
*
At a glance
- Drugs Relenopride (Primary)
- Indications Constipation; Irritable bowel syndrome
- Focus Adverse reactions
- Sponsors SK biopharmaceuticals
- 28 Dec 2012 New trial record